E-LIB Suche - Ergebnisse für: Yung, W.K.A.

1

P11.65.B GBM AGILE: A global, phase 2/3 adaptive platform t..:

Weller, M ; Ellingson, B ; Alexander, B...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii73-ii73 , 2022

Link: https://doi.org/10.1093/..

2

Consensus recommendations for a dynamic susceptibility cont..:

Boxerman, Jerrold L ; Quarles, Chad C ; Hu, Leland S...
Neuro-Oncology. 22 (2020) 9 - p. 1262-1275 , 2020

Link: https://doi.org/10.1093/..

3

Soluble Tie2 overrides the heightened invasion induced by a..:

Cortes-Santiago, Nahir ; Hossain, Mohammad B. ; Gabrusiewicz, Konrad...
Oncotarget. 7 (2016) 13 - p. 16146-16157 , 2016

Link: https://doi.org/10.18632..

4

A phase II study of bevacizumab and erlotinib after radiati..:

Brain Tumor Trials Collaborative ; Raizer, J. J. ; Giglio, P....
Journal of Neuro-Oncology. 126 (2015) 1 - p. 185-192 , 2015

Link: https://doi.org/10.1007/..

5

Phase I/II study of erlotinib and temsirolimus for patients..:

Wen, P. Y. ; Chang, S. M. ; Lamborn, K. R....
Neuro-Oncology. 16 (2014) 4 - p. 567-578 , 2014

Link: https://doi.org/10.1093/..

6

The Somatic Genomic Landscape of Glioblastoma:

Brennan, Cameron W. ; Verhaak, Roel G.W. ; McKenna, Aaron...
Cell. 157 (2014) 3 - p. 753 , 2014

Link: https://doi.org/10.1016/..

7

PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) I..:

Wen, P. Y. ; Wen, P. Y. ; Yung, W. K. A....
Neuro-Oncology. 16 (2014) suppl 3 - p. iii47-iii47 , 2014

Link: https://doi.org/10.1093/..

8

Improved Progression Free Survival In 1p/19q Co-Deleted Ana..:

Mandel, Jacob ; Webre, Courtney ; Shonka, Nicole..
Neurology. 82 (2014) 10_supplement - p. , 2014

Link: https://doi.org/10.1212/..

9

DR-08 * MSK1/-CATENIN SIGNALING MEDIATES RESISTANCE TO PI3K..:

Wu, S. ; Zheng, S. ; Verhaak, R...
Neuro-Oncology. 16 (2014) suppl 5 - p. v64-v64 , 2014

Link: https://doi.org/10.1093/..

10

Brain Malignancy Steering Committee clinical trials plannin..:

Alexander, B. M. ; Galanis, E. ; Yung, W. K. A....
Neuro-Oncology. 17 (2014) 2 - p. 180-188 , 2014

Link: https://doi.org/10.1093/..

11

MS-20 * LEPTOMENINGEAL DISSEMINATION IN RELAPSED ADULT MEDU..:

Penas-Prado, M. ; Puduvalli, V. K. ; Mahajan, A....
Neuro-Oncology. 16 (2014) suppl 5 - p. v131-v131 , 2014

Link: https://doi.org/10.1093/..

12

GE-41 * COMPREHENSIVE AND INTEGRATIVE GENOMIC CHARACTERIZAT..:

Yung, W. K. A. ; Verhaak, R. ; Cooper, L....
Neuro-Oncology. 16 (2014) suppl 5 - p. v105-v105 , 2014

Link: https://doi.org/10.1093/..

13

DECIPHERING INTRINSIC AND ADAPTIVE RESISTANCE TO PI3K PATHW..:

Yung, W. K. A. ; Koul, D. ; Wu, S..
Neuro-Oncology. 16 (2014) suppl 3 - p. iii37-iii38 , 2014

Link: https://doi.org/10.1093/..

14

Identification of prognostic gene signatures of glioblastom..:

Kim, Y.-W. ; Koul, D. ; Kim, S. H....
Neuro-Oncology. 15 (2013) 7 - p. 829-839 , 2013

Link: https://doi.org/10.1093/..

15

Higher impact, wider influence:

Yung, W. K. A.
Neuro-Oncology. 15 (2013) 9 - p. 1113-1113 , 2013

Link: https://doi.org/10.1093/..